HIGH-DOSE CISPLATIN WITH SODIUM THIOSULFATE PROTECTION

被引：145

作者：

PFEIFLE, CE

HOWELL, SB

FELTHOUSE, RD

WOLIVER, TBS

ANDREWS, PA

MARKMAN, M

MURPHY, MP

机构：

[1] UNIV CALIF SAN DIEGO,CTR CANC,DEPT MED,T012,LA JOLLA,CA 92093

[2] UNIV CALIF SAN DIEGO,GEN CLIN RES CTR,LA JOLLA,CA 92093

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1985年 / 3卷 / 02期

关键词：

D O I：

10.1200/JCO.1985.3.2.237

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：237 / 244

页数：8

共 15 条

[1] CLINICAL PHARMACOKINETICS OF INTRAARTERIAL CISPLATIN IN HUMANS [J].

CAMPBELL, TN ;

HOWELL, SB ;

PFEIFLE, CE ;

WUNG, WE ;

BOOKSTEIN, J .

JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (12) :755-762

[2]

Chabner B. A., 1982, CANCER PRINCIPLES PR, P156

[3] DOSE - A CRITICAL FACTOR IN CANCER-CHEMOTHERAPY [J].

FREI, E ;

CANELLOS, GP .

AMERICAN JOURNAL OF MEDICINE, 1980, 69 (04) :585-594

[4]

HAYES DM, 1977, CANCER, V39, P1372, DOI 10.1002/1097-0142(197704)39:4<1372::AID-CNCR2820390404>3.0.CO

[5]

2-J

[6]

HOWELL SB, 1983, CANCER RES, V43, P1426

[7] INTRAPERITONEAL CISPLATIN WITH SYSTEMIC THIOSULFATE PROTECTION [J].

HOWELL, SB ;

PFEIFLE, CL ;

WUNG, WE ;

OLSHEN, RA ;

LUCAS, WE ;

YON, JL ;

GREEN, M .

ANNALS OF INTERNAL MEDICINE, 1982, 97 (06) :845-851

[8]

HOWELL SB, 1980, CANCER TREAT REP, V64, P611

[9]

LEVI J, 1980, J PHARMACOL EXP THER, V213, P545

[10] COMBINATION INTRAPERITONEAL CHEMOTHERAPY WITH CISPLATIN, CYTARABINE, AND DOXORUBICIN FOR REFRACTORY OVARIAN-CARCINOMA AND OTHER MALIGNANCIES PRINCIPALLY CONFINED TO THE PERITONEAL-CAVITY [J].

MARKMAN, M ;

HOWELL, SB ;

LUCAS, WE ;

PFEIFLE, CE ;

GREEN, MR .

JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (12) :1321-1326

← 1 2 →